Peru's economy could plummet by more than 20% if unpaid consumer debts continue to mount, a scenario the government hopes to stave off with an emergency plan to reschedule troubled loans with state guarantees, the government said on Thursday.
More than 100 indigenous activists in Peru´s Amazon occupied infrastructure belonging to the state-run Petroperú pipeline, the company said, demanding improved social benefits and health care in the face of the coronavirus pandemic.
Peru's EMBIG (Emerging Markets Bond Index Global) spread stood at 183 basis points, while the EMBIG Latin America spread increased 52 bps to 494 bps on September 16-23, the Central Reserve Bank (BCR) has reported.
Peru’s Navy was carefully watching a fleet of around 250 Chinese fishing vessels that had sailed just outside the Andean country’s waters, angering the domestic fishing industry and sparking a Twitter war between Washington and Beijing.
Peru will push forward with a gradual reopening of its economy in October, allowing international flights to countries in the region and more people into its restaurants and stores, the government announced, provided coronavirus cases continue to fall.
Brazil and Argentina, Latin American nations seeking more time to commit to the global COVID-19 vaccine facility known as COVAX, said they intend to so as soon as possible after missing Friday’s deadline.
The Peruvian opposition leader Keiko Fujimori, the greatest adversary of President Martín Vizcarra, rejected this Sunday the motion to remove the president and urged Congress to act with prudence.
Peruvian opposition lawmakers filed a censure motion to oust the government’s economy minister, underscoring political tensions as the country rides out its deepest economic plunge in decades due to the coronavirus pandemic.
The number of confirmed coronavirus deaths in Latin America passed 300,000 on Wednesday, according to several independent tallies, with the virus showing no signs of abating in the world's worst-hit region.
Peru will start testing coronavirus vaccines from China's Sinopharm and US drug maker Johnson & Johnson in September, researchers said, which should help the country gain faster access to inoculations once the vaccines are approved.